ArticleInternational journal of hematology2019
Ibrutinib in Japanese patients with relapsed/refractory B-cell malignancies: final analysis of phase I study.
Kensei Tobinai et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it